blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4103717

EP4103717 - COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.11.2022
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  20.08.2021
Most recent event   Tooltip19.08.2024The date on which the examining division becomes responsible, has been established 
19.08.2024Amendment by applicant 
Applicant(s)For all designated states
The Children's Hospital of Philadelphia
3401 Civic Center Boulevard
Philadelphia, PA 19104 / US
[2022/51]
Inventor(s)01 / RANUM, Paul, T.
6804 Nw 52nd Lane
Gainesville, FL 32852 / US
02 / MONTEYS, Alejandro, Mas
822 Bainbridge St.
Philadelphia, PA 19147 / US
03 / HUNDLEY, Amiel, A.
14 Marcy Drive
Neptune, NJ 07753 / US
04 / DAVIDSON, Beverly, L.
440 S. Broad St. 1402
Philadelphia, PA 19146 / US
 [2022/51]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2022/51]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date21754225.712.02.2021
[2022/51]
WO2021US17950
Priority number, dateUS202062975400P12.02.2020         Original published format: US 202062975400 P
[2022/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021163556
Date:19.08.2021
Language:EN
[2021/33]
Type: A1 Application with search report 
No.:EP4103717
Date:21.12.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 19.08.2021 takes the place of the publication of the European patent application.
[2022/51]
Search report(s)International search report - published on:US19.08.2021
(Supplementary) European search report - dispatched on:EP29.01.2024
ClassificationIPC:C12N15/62
[2022/51]
CPC:
C07K14/505 (EP,IL,KR); A61K48/005 (EP,IL,KR,US); C12N15/625 (KR,US);
A61K48/0075 (EP,IL,KR); C07K14/015 (US); C12N15/86 (KR,US);
C07K2319/02 (EP,IL,KR,US); C07K2319/60 (EP,IL); C12N2320/33 (KR,US);
C12N2750/14143 (EP,IL,KR,US); C12N2840/44 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/51]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR INDUZIERBAREN ALTERNATIVEN SPLEISSREGULIERUNG DER GENEXPRESSION[2022/51]
English:COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION[2022/51]
French:COMPOSITIONS ET PROCEDES POUR LA REGULATION INDUCTIBLE DE L'EXPRESSION GENETIQUE PAR EPISSAGE ALTERNATIF[2022/51]
Entry into regional phase07.09.2022National basic fee paid 
07.09.2022Search fee paid 
07.09.2022Designation fee(s) paid 
07.09.2022Examination fee paid 
Examination procedure07.09.2022Examination requested  [2022/51]
15.08.2024Amendment by applicant (claims and/or description)
15.08.2024Date on which the examining division has become responsible
Fees paidRenewal fee
07.09.2022Renewal fee patent year 03
03.01.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2016122780  (ALPHEY LUKE [GB]) [A] 1-15* the whole document *;
 [XP]WO2020033473  (CHILDRENS HOSPITAL PHILADELPHIA [US]) [XP] 1-15 * see the whole document and in particular the claims, Figs. 2-4, 17-20, paragraphs [0006]-[0028], [0093]-[0107] and Example 1. *;
 [A]  - CHEN J ET AL, "Alternative splicing in cancer: implications for biology and therapy", ONCOGENE, NATURE PUBLISHING GROUP UK, LONDON, vol. 34, no. 1, doi:10.1038/ONC.2013.570, ISSN 0950-9232, (20140120), pages 1 - 14, (20140120), XP037749810 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/onc.2013.570
International search[XY]US2011086833  (PAUSHKIN SERGEY V [US], et al) [X] 1,5 * entire document * [Y] 2-4;
 [Y]WO2018098446  (PTC THERAPEUTICS INC [US]) [Y] 2,4 * entire document *;
 [Y]US2019000946  (LANGLADE DEMOYEN PIERRE [FR], et al) [Y] 3 * entire document *;
 [A]US2019264211  (VORECHOVSKY IGOR [GB], et al) [A] 1-5 * entire document *;
 [A]US2019292540  (SINGH RAVINDRA N [US], et al) [A] 1-5* entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.